Divarasib in KRAS G12C mutant tumors
Mosalem
Share Talk
Visit
nejm.org
to learn more
August 30, 2023
10 hr
Default user image
Log in Sign Up
Channels
DiscoveryCardiology
Every Day
COVID
Every Day
Dermatology
Every Day
Endocrinology
Every DayATA 2022ENDO 2022
Gastroenterology
Every DayIBS
Hematology
Every DayIMF Patient & FamilyMiracles For MyelomaASH 2024
Hepatology
Every Day
Nephrology
Every DayASN 2024NKF SCM 22Kidney Week 2022
Neurology
GSA 2025
Oncology
Every DayGastrointestinalHER2+ @ ASCO 2025ESMO 2022
Ophthalmology
Every DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary Care
Every Day
Pulmonology
Every Day
Rheumatology
Every DayHIVACR 2024
Urology
Every Day
Speaker

Description

Divarasib in KRAS G12C mutant tumors
Talk's display image
Divarasib in KRAS G12C mutant tumors